Book icon with persian name of Pubnito
  • Mağaza
  • Kütüphane
  • Sepetiniz


    Tüm nesneler:0

    Sepeti Görüntüle

    Frontiers in Clinical Drug Research - CNS and Neurological Disorders: Volume 8

    Frontiers in Clinical Drug Research - CNS and Neurological Disorders: Volume 8

    Atta-ur-Rahman Zareen Amtul

    "Frontiers in Clinical Drug Research - CNS and Neurological Disorders is a book series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of central nervous system (CNS) and other nerve disorders. The scope of the book series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of contemporary molecular targets involved in neurological and CNS disorders. Reviews presented in the series are mainly focused on clinical and therapeutic aspects of novel drugs intended for these targets. Frontiers in Clinical Drug Research - CNS and Neurological Disorders is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critical information for developing clinical trials and devising research plans in the field of neurology. The eighth volume of this series features reviews that cover the following topics related to the treatment of a variety of CNS disorders, related diseases and basic research: - Emerging Innovative Therapies of Spinal Muscular Atrophy: Current Knowledge and Perspectives - Obesity Induced by The Neurological Drugs - Molecular Mechanism of Nervous System Disorders and Implications for New Therapeutic Targets - Glioma Imaging and Novel Agents - Screening Models for Neuroleptic Drug-Induced Hyperprolactinemia: A Mini-Review" "Frontiers in Clinical Drug Research - CNS and Neurological Disorders is a book series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of central nervous system (CNS) and other nerve disorders. The scope of the book series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of contemporary molecular targets involved in neurological and CNS disorders. Reviews presented in the series are mainly focused on clinical and therapeutic aspects of novel drugs intended for these targets. Frontiers in Clinical Drug Research - CNS and Neurological Disorders is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critical information for developing clinical trials and devising research plans in the field of neurology. The eighth volume of this series features reviews that cover the following topics related to the treatment of a variety of CNS disorders, related diseases and basic research: - Emerging Innovative Therapies of Spinal Muscular Atrophy: Current Knowledge and Perspectives - Obesity Induced by The Neurological Drugs - Molecular Mechanism of Nervous System Disorders and Implications for New Therapeutic Targets - Glioma Imaging and Novel Agents - Screening Models for Neuroleptic Drug-Induced Hyperprolactinemia: A Mini-Review"

    kitap formatı

    kitap lisansı

    $ 69.00

    Yorumlar

    Derecelendirme Anlık Görüntüsü

    İncelemeleri filtrelemek için aşağıdan bir satır seçin.

    0

    0

    0

    0

    0

    0

    Genel

    Ortalama Müşteri Puanları

    Bu Kitap için İnceleme

    Düşüncelerinizi diğer okuyucularla paylaşın

    Daha Fazla Bilgi

    description_of_book

    "Frontiers in Clinical Drug Research - CNS and Neurological Disorders is a book series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the

    Ek Bilgi

    SATICI

    Yayın tarihi

    2020 Nov 03

    Yazarlar
    Atta-ur-Rahman Zareen Amtul

    ISBN

    9789811470080

    Yazarlar Hakkında

    Atta-ur-Rahman
    Atta-ur-Rahman
    Atta-ur-Rahman
     Zareen Amtul
    Zareen Amtul
    Zareen Amtul

    İçindekiler

    logo

    Türkçe

    PUBNiTO tarafından desteklenmektedir | © 2024 Notion Wave A.Ş.